MyBCTeam

Immunotherapy can be added to chemotherapy before or after surgery for people with recurrent triple-negative breast cancer (TNBC) that cannot be removed by surgery and in people with metastatic TNBC. Studies show that compared to chemotherapy alone, pembrolizumab along with chemotherapy can give some people with TNBC more Show Full Answer

Immunotherapy can be added to chemotherapy before or after surgery for people with recurrent triple-negative breast cancer (TNBC) that cannot be removed by surgery and in people with metastatic TNBC. Studies show that compared to chemotherapy alone, pembrolizumab along with chemotherapy can give some people with TNBC more time before their cancer spreads. Each person's treatment plan may vary based on their specific needs.

For more detailed information, you can refer to the following sources from the knowledge base:
- [Immunotherapy for Triple-Negative Breast Cancer: 6 Facts To Know](https://www.mybcteam.com/resources/immunotherap...)
- [Immunotherapy for Breast Cancer: What To Expect](https://www.mybcteam.com/resources/immunotherap...)

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Immunotherapy for Breast Cancer: What To Expect | MyBCTeam

Immunotherapy for Triple-Negative Breast Cancer: 6 Facts To Know | MyBCTeam